Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Safety and Efficacy of Interferon γ in Friedreich's Ataxia

This study reports the results of an open-label clinical trial testing the safety and efficacy of recombinant human interferon γ (IFNγ)-1b in a group of 12 young FRDA patients treated for 6 months.

Read the entire article HERE

SHARE

FacebookTwitterLinkedInYoutube
Family B.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News


Site Map     Privacy Policy     Service Terms     Log-in     Contact     Charity Navigator